Table 4.
Treatment | Normal | Control | Bisacodyl | Lactobacillus bulgaricus | LF-Suo (×109 CFU/kg b.w.) | |
---|---|---|---|---|---|---|
0.1 (g) | 1.0 (g) | |||||
1–6 Days (Dose with samples) | ||||||
Defecation weight (g) | 0.90 ± 0.09 | 0.94 ± 0.11 | 1.13 ± 0.07 | 0.91 ± 0.05 | 0.92 ± 0.08 | 0.91 ± 0.05 |
Particle counts of defecation | 35 ± 4 | 36 ± 7 | 49 ± 6 | 36 ± 2 | 36 ± 5 | 37 ± 5 |
Water content of defecation (%) | 47 ± 4 | 47 ± 5 | 55 ± 5 | 49 ± 4 | 45 ± 5 | 46 ± 6 |
7–9 Days (High concentration dose with samples and activated carbon) | ||||||
Defecation weight (g) | 0.91 ± 0.05 | 0.37 ± 0.06 | 0.74 ± 0.15 | 0.40 ± 0.05 | 0.58 ± 0.04 | 0.67 ± 0.09 |
Particle counts of defecation | 36 ± 3 | 19 ± 6 | 38 ± 5 | 21 ± 3 | 27 ± 5 | 31 ± 4 |
Water content of defecation (%) | 46 ± 5 | 16 ± 3 | 40 ± 3 | 23 ± 2 | 29 ± 3 | 36 ± 4 |
n = 10 ICR mice in each group, bisacodyl: 100 mg/kg b.w.; Lactobacillus bulgaricus: 1.0 × 109 CFU/kg b.w.; and LF-Suo: Lactobacillus fermentum Suo.